2-氮杂环丁烷羧酸甲酯 | 134419-57-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氮杂环丁烷羧酸甲酯
• 中文别名: 氮杂环-2-羧酸甲酯
• 英文名称: (2S)-methyl azetidine-2-carboxylate
• 英文别名: azetidine-2-carboxylic acid methyl ester；methyl azetidine-2-carboxylate；methyl 2-azetidinecarboxylate；methyl 2(S)-azetidinecarboxylate；Azetidin-2-carbonsaeure-methylester
• CAS: 134419-57-1
• 化学式: C₅H₉NO₂
• 分子量: 115.132
• InChiKey: CHNOQXRIMCFHKZ-UHFFFAOYSA-N

物化性质

• 沸点：
  144.7±33.0 °C(Predicted)
• 密度：
  1.100±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  2-氮杂环丁烷羧酸甲酯 在 硫代乙酸 作用下， 以 甲醇 为溶剂， 生成 methyl 4-amino-2-mercaptobutanoate
  参考文献：
  名称：

  [EN] SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
  [FR] DÉGRONIMÈRES SPIROCYCLIQUES POUR LA DÉGRADATION DE PROTÉINES CIBLES

  摘要：

  这项发明提供了具有螺环式E3泛素连接酶靶向基团（Degrons）的化合物，这些化合物可以直接使用，也可以与靶向配体连接，用于选定用于体内降解的蛋白质，并提供了使用方法、组合物以及其制备方法。

  公开号：

  WO2017197036A1
• 作为产物：
  描述：

  N-苄基-2-氮杂环丁酸甲酯 在 palladium on activated charcoal ammonium formate 作用下， 以 甲醇 为溶剂， 反应 0.75h， 生成 2-氮杂环丁烷羧酸甲酯
  参考文献：
  名称：

  Ring Expansion of Azetidinium Ylides:  Rapid Access to the Pyrrolizidine Alkaloids Turneforcidine and Platynecine

  摘要：

  Azetidinecarboxylate esters react readily with metallocarbenes in an inter- or intramolecular fashion to generate azetidinium ylides. Efficient [1,2]-shift by the ester-substituted carbon furnishes ring-expanded pyrrolidine products. In the case of substrate 1, this provides access to the pyrrolizidine alkaloids turneforcidine and platynecine via a high-yield, five-step sequence starting with readily available methyl 1-benzylazetidine-2-carboxylate.

  DOI：

  10.1021/ol050915o

文献信息

• [EN] NAPHTHYRIDINONE DERIVATIVES AS INHIBITORS OF CYTOMEGALOVIRUS DNA POLYMERASE<br/>[FR] DÉRIVÉS DE NAPHTHYRIDINONE EN TANT QU'INHIBITEURS D'ADN POLYMÉRASE DU CYTOMÉGALOVIRUS
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2013152063A1

  公开（公告）日：2013-10-10

  Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

  式（I）中n、m、R1、R2、R3、R4、R5和R6的化合物，适用于巨细胞病毒疾病和/或感染的治疗。
• Cathepsin cysteine protease inhibitors
  申请人：——

  公开号：US20030229226A1

  公开（公告）日：2003-12-11

  This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of Cathepsins K and L. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

  这项发明涉及一类新型化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于对卡特普辛K和L的抑制剂。这些化合物可用于治疗需要抑制骨吸收的疾病，如骨质疏松症。
• Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
  申请人：Ortho-McNeil Pharmaceutical, Inc.

  公开号：US06544976B1

  公开（公告）日：2003-04-08

  This invention provides compounds having the following general structure: This invention also provides pharmaceutical compositions comprising same and methods of using these compositions to treat and prevent disorders characterized by neuronal damage.

  这项发明提供具有以下一般结构的化合物。这项发明还提供包含相同化合物的药物组合物，以及使用这些组合物来治疗和预防以神经元损伤为特征的疾病的方法。
• Synthesis of bridged azabicyclic compounds using radical translocation reactions of 1-(o-halogenobenzoyl)-2-(prop-2-enyl)- and -(prop-2-ynyl)-piperidines
  作者：Masazumi Ikeda、Yasuhiro Kugo、Tatsunori Sato

  DOI：10.1039/p19960001819

  日期：——

  Methyl 1-(o-bromobenzoyl)-2-(prop-2-enyl)piperidine-2-carboxylate 8a, upon treatment with tributyltin hydride in the presence of azoisobutyronitrile in boiling toluene gave regioselectively the 8-azabicyclo[3.2.1]octane 14a (a 5-exo cyclisation product) in quantitative yield as a diastereomeric mixture (66:34). 1-(o-Bromobenzoyl)-2-(prop-2-enyl)piperidine 13 also gave the 8-azabicyclo[3.2.1]octane

  1-（邻-溴苯甲酰基）-2-（丙-2-基）哌啶-2-羧酸甲酯8a，在沸腾的甲苯中，在偶氮异丁腈存在下，用氢化三丁基锡处理，区域选择性地生成8-氮杂双环[3.2.1]辛烷以非对映异构体混合物的定量收率得到14a（5- exo环化产物）（66:34）。1-（邻-溴苯甲酰基）-2-（丙-2-烯基）哌啶13还得到了8-氮杂双环[3.2.1]辛烷16（75％，为非对映异构体混合物），以及吡啶基[2,1- α ]异吲哚酮17（10％）和简单还原产物18（5％）。1-（ø -Iodobenzoyl）-2- [3-（三甲硅烷基）丙-2-炔基]哌啶23得到，除了吡啶并[2,1-一个]异吲哚酮25（18％），8-氮杂双环[3.2.1]辛烷24（75％），其被转化为6-氧代衍生物27。为了比较，还研究了氮杂环丁烷同源物31的行为。
• A new class of analog of the bifunctional radiosensitizer .alpha.-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines
  作者：Mark J. Suto、Michael A. Stier、Leslie M. Werbel、Carla M. Arundel-Suto、Wilbur R. Leopold、William E. Elliott、Judith S. Sebolt-Leopold

  DOI：10.1021/jm00112a026

  日期：1991.8

  A series of compounds related to alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069, 1) were synthesized and evaluated as selective hypoxic cell cytotoxic agents and as radiosensitizers. The aziridine moiety was replaced with a number of other potential alkylating groups including cycloalkylaziridines and azetidines. The data indicated that modification of the aziridine of 1 resulted in a substantial decrease in the ability of the compounds to selectively kill hypoxic cells. However, these modifications did not affect the compounds' in vitro radiosensitizing activity since many of the derivatives were as potent as 1. All of the compounds that were evaluated in vivo were less toxic than 1, and several members of this series had significant activity. The best compound was trans-alpha-[[(4-bromotetrahydro-2H-pyran-3-yl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol (18), which, due to its activity and log P value, is a candidate for additional in vivo studies.